Serum antibodies to GM1, GD1b, peripheral nerve myelin, and Campylobacter jejuni in patients with Guillain‐Barré syndrome and controls: Correlation and prognosis
The DOI matches its Crossref record.
Abstract
Serum antibodies to monosialoganglioside (GM1), disialoganglioside (GD1b), and Campylobacter jejuni, measured by enzyme‐linked immunosorbent assay and serum antibodies to peripheral nerve myelin, measured by the C1 fixation and transfer assay, were studied in 58 acute‐phase patients with Guillain‐Barré syndrome (GBS), 42 disease controls, and 29 normal controls. Anti‐peripheral nerve myelin antibodies were elevated in 57 of 58 patients with GBS compared with controls, whereas only 8.6% had increased antibody titers to GM1 and 10.3% to GD1b. Only low antibody titers (GM1) or no antibodies (GD1b) were found in controls. More GBS patients (17.2%) than controls (7%) had antibodies to C jejuni. Poor recovery with inability to walk at 1 year after onset of symptoms was seen in 3 (5%) of the patients with GBS. All 3 patients had serological evidence of recent C jejuni infection but no antibodies to GM1 or GD1b. GBS patients with antibodies to GM1 or GD1b had excellent recovery. Our data indicate that antibodies to GM1 or GD1b do not necessarily mediate the extensive axonal damage seen in these severely affected patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Willison, H. J., Jacobs, B. C., & van Doorn, P. A. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00339-1 · Cited by 1,609
Peripheral neuropathies and anti-glycolipid antibodies
Willison, H. J. (2002) · Brain · doi:10.1093/brain/awf272 · Cited by 710
Campylobacter Species and Guillain-Barré Syndrome
Nachamkin, I., Allos, B. M., & Ho, T. (1998) · Clinical Microbiology Reviews · doi:10.1128/cmr.11.3.555 · Cited by 590
Clinical and Epidemiologic Features of Guillain‐Barré Syndrome
Hughes, R. A. C., & Rees, J. H. (1997) · The Journal of Infectious Diseases · doi:10.1086/513793 · Cited by 456
Pathogenesis of Guillain–Barré syndrome
Hughes, R. A. C., Hadden, R. D. M., Gregson, N. A., & Smith, K. J. (1999) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(99)00195-2 · Cited by 405
Metadata
- Authors
- Vriesendorp, F. J., Mishu, B., Blaser, M. J., & Koski, C. L.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 1993-08
- Volume
- 34
- Issue
- 2
- Pages
- 130-135
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2074414482
- Cited by
- 150
- References
- 0
- FWCI
- 11.18
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Serum antibodies to GM1, GD1b, peripheral nerve myelin, and Campylobacter jejuni in patients with Guillain‐Barré syndrome and controls: Correlation and prognosis. https://app.cochat.ai/papers/10.1002/ana.410340206
- The paper
- Vriesendorp, F. J., Mishu, B., Blaser, M. J., & Koski, C. L. (1993). Serum antibodies to GM1, GD1b, peripheral nerve myelin, and Campylobacter jejuni in patients with Guillain‐Barré syndrome and controls: Correlation and prognosis. Annals of Neurology. https://doi.org/10.1002/ana.410340206
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.